:Since the third version of Asian-Pacific consensus on the management of hepatitis B was published in June 2005, Pegylated interferon α2a, entecavir and telbivudine have been approved globally and several updated guidelines on chronic hepatitis B have been published. In addition, large volume of new data on the natural history and treatment of chronic hepatitis B have become available.
当前位置：医师网首页 → 课件下载 → 消化 → 肝胆疾病 
